TY - JOUR
T1 - Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer
AU - Hoshi, Senji
AU - Ohyama, Chikara
AU - Hagisawa, Shigeru
AU - Ono, Kunio
AU - Satoh, Makoto
AU - Saito, Seiichi
AU - Fukuzaki, Atushi
AU - Arai, Yoichi
PY - 2003/4
Y1 - 2003/4
N2 - Many types of chemotherapy are now being attempted all over the world for hormone-refractory prostate cancer (HRPC) patients, and prostate-specific antigen (PSA) reduction in almost half of the treated patients has been reported. However, only a few studies have reported the response of bone metastasis. The authors report a patient with HRPC who obtained complete regression of bone metastases on super bone scan by biochemical modulation (BM), dexamethasone, and endocrine therapy.
AB - Many types of chemotherapy are now being attempted all over the world for hormone-refractory prostate cancer (HRPC) patients, and prostate-specific antigen (PSA) reduction in almost half of the treated patients has been reported. However, only a few studies have reported the response of bone metastasis. The authors report a patient with HRPC who obtained complete regression of bone metastases on super bone scan by biochemical modulation (BM), dexamethasone, and endocrine therapy.
KW - Biochemical modulation
KW - Hormone-refractory prostate cancer
KW - Regression
KW - Super bone scan
UR - http://www.scopus.com/inward/record.url?scp=0038674622&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038674622&partnerID=8YFLogxK
U2 - 10.1007/s101470300021
DO - 10.1007/s101470300021
M3 - Article
C2 - 12720106
AN - SCOPUS:0038674622
SN - 1341-9625
VL - 8
SP - 118
EP - 120
JO - International Journal of Clinical Oncology
JF - International Journal of Clinical Oncology
IS - 2
ER -
